SOPHiA GENETICS Company

SOPHiA GENETICS is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDMв„ў Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDMв„ў Platform and related solutions, products and services are currently used by more than 780 hospital, laboratory and biopharma institutions globally.
Technology: Early drug development, Intelligent Data Analysis
Industry: Early Drug Development, Healthcare & Life Sciences
Headquarters: Boston, United States
Founded Date: 01.01.2011
Employees Number: 251-500
Funding Status: Late Stage Venture
Acquisitions Number: 1
Investors Number: 19
Total Funding: 250152150
Estimated Revenue: $50M to $100M
Last Funding Date: 01.10.2020
Last Funding Type: Series F

Visit Website
info@sophiagenetics.com
https://twitter.com/SOPHiAGENETICS
Register and Claim Ownership